Recorded at the 2025 American Heart Association Scientific Sessions, hosts Manesh Patel and Emily O'Brien discuss late-breaking cardiovascular research, including gene-editing therapy for cholesterol, AFib management strategies, and, for coffee lovers, the DECAF trial's findings on caffeine and heart rhythm.
#AHA25 #beyondtheendpoint #cardiology #podcast #hearthealth #clinicalresearch
All content for Beyond the Endpoint is the property of Duke Clinical Research Institute and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Recorded at the 2025 American Heart Association Scientific Sessions, hosts Manesh Patel and Emily O'Brien discuss late-breaking cardiovascular research, including gene-editing therapy for cholesterol, AFib management strategies, and, for coffee lovers, the DECAF trial's findings on caffeine and heart rhythm.
#AHA25 #beyondtheendpoint #cardiology #podcast #hearthealth #clinicalresearch
Assessing Results of Open-label, Comparative Effectiveness Trials for Cardio-metabolic Drugs
Beyond the Endpoint
17 minutes 3 seconds
5 years ago
Assessing Results of Open-label, Comparative Effectiveness Trials for Cardio-metabolic Drugs
Assessing Results of Open-label, Comparative Effectiveness Trials for Cardio-metabolic Drugs by Duke Clinical Research Institute
Beyond the Endpoint
Recorded at the 2025 American Heart Association Scientific Sessions, hosts Manesh Patel and Emily O'Brien discuss late-breaking cardiovascular research, including gene-editing therapy for cholesterol, AFib management strategies, and, for coffee lovers, the DECAF trial's findings on caffeine and heart rhythm.
#AHA25 #beyondtheendpoint #cardiology #podcast #hearthealth #clinicalresearch
